MPWT
PRAX icon

MassMutual Private Wealth & Trust’s Praxis Precision Medicines PRAX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670 Sell
2
-5
-71% -$1.58K ﹤0.01% 2239
2026
Q1 		$2.25K Buy
+7
New +$2.17K ﹤0.01% 1947

Other funds holding PRAX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MassMutual Private Wealth & Trust's PRAX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Praxis Precision Medicines (PRAX) stake by 71% in Q2 2026, selling an estimated $1.58K and leaving 2 shares worth $670. The position accounts for ﹤0.01% of the portfolio, ranked #2239.

MassMutual Private Wealth & Trust first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.25K in Q1 2026. 74 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 2 shares of Praxis Precision Medicines worth $670 as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 5 Praxis Precision Medicines shares in Q2 2026, an estimated $1.58K.
  • Praxis Precision Medicines made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2239 holding.
  • MassMutual Private Wealth & Trust first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • MassMutual Private Wealth & Trust's Praxis Precision Medicines position peaked at $2.25K in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.